🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the efficacy and safety of trastuzumab deruxtecan ...
Status
Active Not Recruiting
Location
Instituto Medico Especializado Alexander Fleming
Start Date
2021-05-21
Trial ID
NCT04704934
Treatments Being Tested
The purpose of this study is to investigate whether there are no clinically...
Status
Completed
Location
ImClone Investigational Site
Start Date
2012-07-19
Trial ID
NCT01515306
Treatments Being Tested
The main purpose of this study is to establish the safety and the recommend...
Status
Active Not Recruiting
Location
HonorHealth Research Institute
Start Date
2019-04-26
Trial ID
NCT03872947
The purpose of this study is to determine whether nab-Paclitaxel (Abraxane®...
Status
Completed
Location
Rocky Mountain Cancer Centers
Start Date
2015-05-05
Trial ID
NCT02317991
Treatments Being Tested
This is a randomized, open-label, multicenter phase III trial of ramuciruma...
Status
Unknown
Location
Maria Di Bartolomeo
Start Date
2016-12
Trial ID
NCT02934464
Treatments Being Tested
This phase II trial compares cabozantinib alone and the combination of cabo...
Status
Active Not Recruiting
Location
Veterans Administration Medical Center - Birmingham
Start Date
2020-07-13
Trial ID
NCT04310007
This is a multicentric study. All patients with TET (thymic epithelial tumo...
Status
Unknown
Location
Fondazione IRCCS Istituto Nazionale dei Tumori
Start Date
2018-11-01
Trial ID
NCT03921671
Treatments Being Tested
ARMANI-2/ENGIC8 is a randomized, open-label, phase III trial evaluating a s...
Status
Not Yet Recruiting
Location
Krankenhaus Nordwest
Start Date
2026-09-01
Trial ID
NCT07763171
The project is primarily aimed at identifying and subsequently validating t...
Status
Unknown
Location
University of Pisa
Start Date
2021-11-01
Trial ID
NCT05301465
This is a single-arm phase I/Ib study of crenolanib combined with ramucirum...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2017-04-14
Trial ID
NCT03193918
Treatments Being Tested